BY9-64419-76365
3 vaccinations
6 coded responses
32 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 960 / CA
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
- 2020-12-16
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
-
2020-12-22
Survey response — days 1–6 daily, dose 1MedDRA: Arthralgia, Exercise tolerance decreased — Feeling: Good · Site: Pain · Joint painsFree text: I can not exercise like I usually do, joint painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-30
- 2021-01-06
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-13
- 2021-02-19
- 2021-04-09
-
2021-07-09
Survey response — 6 months, dose 2MedDRA: Arthralgia, Immunisation reaction, Myalgia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Muscle joint pain reaction to Fosamax, just like Covid vaccine reactionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-09
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-15
-
2021-10-18
Dose 3 — Pfizer-BioNTech
- 2021-10-20
-
2021-10-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint painsAdult check-in
-
2021-10-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-10-23
Health check-in — days 1–6 daily, dose 3Feeling: Good · Joint pains, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-10-24
- 2021-10-27
- 2021-11-01
-
2021-11-09
Survey response — day 21, dose 3MedDRA: Epstein-Barr virus infection, Fatigue, Hepatic enzyme increased, Loss of personal independence in daily activities — Feeling: Good · Be unable to do your normal daily activitiesFree text: Abnl high liver enzymes x6 month, fatigue causing me to stop daily exercising.labs showed recent Epstein Barr virus, now resolved. I still worked at hospital as RPH. Still fatigued at timesMedDRA releases: 2024-11 · check-in free text available
-
2021-11-15
Survey response — day 28, dose 3MedDRA: Epstein-Barr virus infection, Fatigue, Hepatic enzyme increased — Feeling: GoodFree text: Positive Epstein Barr virus in last 6 months with elevated liver enzymes. Still more fatigue than I should have.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-22
-
2021-11-29
Survey response — day 42, dose 3MedDRA: Arthralgia — Feeling: FairFree text: Arthralgia in back,MedDRA releases: 2024-11 · check-in free text available
- 2022-01-19
-
2022-10-20
Survey response — 12 months, dose 3MedDRA: Hepatic enzyme increased, Hepatic steatosis, Low density lipoprotein increased — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Transient liver enzymes mild fatty liver disease ldl 180MedDRA releases: 2024-11 · check-in free text available
-
2022-10-20
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-21
- 2022-10-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-10-18 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): I can not exercise like I usually do, joint pain
Release 9 — 6 months, dose 2
Symptoms: Muscle joint pain reaction to Fosamax, just like Covid vaccine reaction
Release 10 — day 21, dose 3
Symptoms: Abnl high liver enzymes x6 month, fatigue causing me to stop daily exercising.labs showed recent Epstein Barr virus, now resolved. I still worked at hospital as RPH. Still fatigued at times
Release 10 — day 28, dose 3
Symptoms: Positive Epstein Barr virus in last 6 months with elevated liver enzymes. Still more fatigue than I should have.
Release 10 — day 42, dose 3
Symptoms: Arthralgia in back,
Release 12 — 12 months, dose 3
Symptoms: Transient liver enzymes mild fatty liver disease ldl 180
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Epstein-Barr virus infection | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hepatic enzyme increased | · | · | ✓ |
| SD | Hepatic steatosis | · | · | ✓ |
| SD | Immunisation reaction | ✓ | ✓ | ✓ |
| SD | Loss of personal independence in daily activities | · | · | ✓ |
| SD | Low density lipoprotein increased | · | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Exercise tolerance decreased | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release